Burren Capital Advisors Ltd Purchases New Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Key Points

• Burren Capital Advisors Ltd acquired 45,095 shares of Walgreens Boots Alliance, valued at approximately $504,000, making it the fund's 16th largest holding.
• Walgreens Boots Alliance reported earnings per share of $0.38 for the most recent quarter, exceeding the consensus estimate by $0.04, with revenue of $38.99 billion, up 7.2% year-over-year.
• The stock currently holds a consensus rating of "Hold" from analysts, with a consensus price target set at $10.59.

Burren Capital Advisors Ltd purchased a new stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 45,095 shares of the pharmacy operator's stock, valued at approximately $504,000. Walgreens Boots Alliance makes up 1.8% of Burren Capital Advisors Ltd's investment portfolio, making the stock its 16th largest holding.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Skandinaviska Enskilda Banken AB publ boosted its stake in Walgreens Boots Alliance by 13.7% in the first quarter. Skandinaviska Enskilda Banken AB publ now owns 165,971 shares of the pharmacy operator's stock valued at $1,856,000 after acquiring an additional 20,000 shares during the last quarter. Cetera Investment Advisers boosted its stake in Walgreens Boots Alliance by 5.5% in the first quarter. Cetera Investment Advisers now owns 164,242 shares of the pharmacy operator's stock valued at $1,835,000 after acquiring an additional 8,602 shares during the last quarter. Vestor Capital LLC bought a new position in Walgreens Boots Alliance in the first quarter valued at approximately $45,000. Venturi Wealth Management LLC boosted its stake in Walgreens Boots Alliance by 244.8% in the first quarter. Venturi Wealth Management LLC now owns 10,348 shares of the pharmacy operator's stock valued at $116,000 after acquiring an additional 7,347 shares during the last quarter. Finally, Oak Thistle LLC boosted its stake in Walgreens Boots Alliance by 399.4% in the first quarter. Oak Thistle LLC now owns 59,625 shares of the pharmacy operator's stock valued at $666,000 after acquiring an additional 47,686 shares during the last quarter. Institutional investors and hedge funds own 58.59% of the company's stock.

Analysts Set New Price Targets

A number of equities analysts have issued reports on the stock. UBS Group reaffirmed a "neutral" rating on shares of Walgreens Boots Alliance in a research note on Thursday, June 26th. Morgan Stanley reissued an "underweight" rating on shares of Walgreens Boots Alliance in a research report on Thursday, June 26th. Finally, Wall Street Zen began coverage on shares of Walgreens Boots Alliance in a research report on Wednesday, May 21st. They set a "hold" rating on the stock. Four equities research analysts have rated the stock with a sell rating, seven have given a hold rating and two have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus price target of $10.59.

Walgreens Boots Alliance Stock Up 0.2%

Shares of NASDAQ:WBA traded up $0.03 during midday trading on Wednesday, reaching $11.65. 1,645,615 shares of the company were exchanged, compared to its average volume of 16,263,487. The firm has a market cap of $10.08 billion, a PE ratio of -1.60, a P/E/G ratio of 1.37 and a beta of 0.78. The stock has a fifty day simple moving average of $11.40 and a two-hundred day simple moving average of $11.13. Walgreens Boots Alliance, Inc. has a fifty-two week low of $8.08 and a fifty-two week high of $13.25. The company has a quick ratio of 0.32, a current ratio of 0.60 and a debt-to-equity ratio of 0.96.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last released its quarterly earnings data on Thursday, June 26th. The pharmacy operator reported $0.38 earnings per share for the quarter, topping the consensus estimate of $0.34 by $0.04. The company had revenue of $38.99 billion for the quarter, compared to analyst estimates of $36.72 billion. Walgreens Boots Alliance had a negative net margin of 4.07% and a positive return on equity of 17.66%. Walgreens Boots Alliance's revenue for the quarter was up 7.2% compared to the same quarter last year. During the same period in the previous year, the business earned $0.63 EPS. As a group, sell-side analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.